Amgen (AMGN) stock is in focus as partner Kissei (KSPHF) reports 20 deaths linked to the U.S. company's rare disease drug.
Twenty people in Japan died after taking Tavneos, though it's unclear whether the drug killed those people, a media report ...
About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease ...
Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...
The Manila Times on MSN
Japan pharma firm warns against rare diseases drug after deaths
TOKYO — A Japanese pharmaceutical firm has warned doctors against prescribing a drug for rare autoimmune diseases to new patients following the deaths of 20 people who took it. Kissei Pharmaceutical, ...
Bengaluru: About 20 deaths linked to ​serious liver dysfunction have been ​reported in Japan in patients treated with Amgen's ...
After death of his father, Reed Jobs is keen for his $1bn venture capital fund Yosemite to make a difference ...
A unicorn is a privately held, venture-backed startup with a reported valuation of $1 billion or more. Coined in 2013, the ...
Free Malaysia Today on MSN
Japanese drugmaker urges doctors not to use Tavneos for new patients
Kissei Pharmaceutical's notice to healthcare professionals came after 20 deaths possibly linked to the drug were reported in Japan.
Karim Iskander testified about his sons, the crash and its aftermath during a wrongful death trial. Here's what he said.
Japan's Kissei Pharmaceutical Co. has started urging doctors to refrain from using Tavneos, a drug used to treat rare kidney ...
Japan's Kissei Pharmaceutical Co. has started urging doctors to refrain from using Tavneos, a drug used to treat rare kidney diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results